Abstract
Locally acquired HEV infection is increasingly recognized in developed countries. Anti-HEV IgG seroprevalence has been shown to be high in haemodialysis patients in a number of previous studies, employing assays of uncertain sensitivity. The aim of this study was to investigate anti-HEV IgG seroprevalence in recipients of haemodialysis and renal transplants compared to a control group using a validated, highly sensitive assay.
Original language | English |
---|---|
Pages (from-to) | 266-271 |
Number of pages | 6 |
Journal | Journal of Medical Virology |
Volume | 85 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2013 |
Keywords
- hepatitis E
- seroprevalence
- renal transplants
- haemodialysis patients